Remicade Maker Moves for Summary Judgment

ST. LOUIS, Mo. - Remicade manufacturer Centocor Inc. recently moved for summary judgment in a case involving a woman who allegedly developed tuberculosis after using the biologic treatment for rheumatoid arthritis. Janet Rolwes v. Centocor Inc., et al. No. 03-CV-00151-CAS (E.D. Mo., Eastern Div.).

Centocor asserted in its Feb. 17 motion that plaintiff Janet Rolwes cannot establish a causal link between her development of tuberculosis and Remicade, and that the company adequately warned her treating physician that some patients using the biologic treatment had suffered similar adverse events.

In January 2003, Rolwes sued Centocor and parent company Johnson & Johnson …